Search

Ketis, N, V, J Lawler, R L Hoover, and M J Karnovsky. 1988. “Effects of Heat Shock on the Expression of Thrombospondin by Endothelial Cells in Culture.”. The Journal of Cell Biology 106 (3): 893-904.

Coetzer, T, J Lawler, J T Prchal, and J Palek. 1987. “Molecular Determinants of Clinical Expression of Hereditary Elliptocytosis and Pyropoikilocytosis.”. Blood 70 (3): 766-72.

Sloand, E M, D M Kenney, F C Chao, J Lawler, and J L Tullis. 1987. “Platelet Antithrombin Defect in Malignancy: Platelet Protein Alterations.”. Blood 69 (2): 479-85.

Dainiak, N, S Kreczko, A Cohen, R Pannell, and J Lawler. 1985. “Primary Human Marrow Cultures for Erythroid Bursts in a Serum-Substituted System.”. Experimental Hematology 13 (10): 1073-9.

Lawler, J, T L Coetzer, J Palek, H S Jacob, and N Luban. 1985. “Sp Alpha I/65: A New Variant of the Alpha Subunit of Spectrin in Hereditary Elliptocytosis.”. Blood 66 (3): 706-9.

Dainiak, N, G Davies, M Kalmanti, J Lawler, and V Kulkarni. 1983. “Platelet-Derived Growth Factor Promotes Proliferation of Erythropoietic Progenitor Cells in Vitro.”. The Journal of Clinical Investigation 71 (5): 1206-14.

Margossian, S S, J W Lawler, and H S Slayter. 1981. “Physical Characterization of Platelet Thrombospondin.”. The Journal of Biological Chemistry 256 (14): 7495-500.

Lawler, J W, and H S Slayter. 1981. “The Release of Heparin Binding Peptides from Platelet Thrombospondin by Proteolytic Action of Thrombin, Plasmin and Trypsin.”. Thrombosis Research 22 (3): 267-79.

Matuszewska, Kathy, Madison Pereira, Duncan Petrik, Jack Lawler, and Jim Petrik. 2021. “Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake.”. Cancers 13 (17).

Desai, Pratik, Alex Helkin, Adeola Odugbesi, Jeff Stein, David Bruch, Jack Lawler, Kristopher G Maier, and Vivian Gahtan. 2017. “Fluvastatin Inhibits Intimal Hyperplasia in Wild-Type But Not Thbs1-Null Mice.”. The Journal of Surgical Research 210: 1-7.